Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Chapman Rowan EDirector | Grant or award | A | — 103 sh | Jun 30, 2026 |
| 5 | Hanna John Walter JRDirector, President and CEO | Option exercise · 10b5-1 plan | M | — 706 sh | Jun 30, 2026 traded Jun 4, 2026 |
| 5 | Dorrance Bennett JRDirector | Grant or award | A | — 1,855 sh | Jun 30, 2026 traded Jun 29, 2026 |
| 5 | Modi Rajeev A.SEE REMARKS | Grant or award | A | $1,477 60 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 5 | Shackley Brian CharlesSVP, Chief Accounting Officer | Option exercise | M | — 953 sh | Jun 30, 2026 traded Jun 29, 2026 |
| 5 | Mehmel Robert FPresident and COO | Open-market sale · 10b5-1 plan | SELL | $22K 230 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 5 | Hanna John Walter JRDirector, President and CEO | Option exercise · 10b5-1 plan | M | — 15.7K sh | Jun 30, 2026 traded Jun 15, 2026 |
| 5 | Hanna John Walter JRDirector, President and CEO | Option exercise · 10b5-1 plan | M | $327K 39.9K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 5 | Mehmel Robert FPresident and COO | Open-market sale · 10b5-1 plan | SELL | $390 4 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 5 | Hanna John Walter JRDirector, President and CEO | Option exercise · 10b5-1 plan | M | — 13.6K sh | Jun 30, 2026 traded Jun 11, 2026 |
| 5 | Mehmel Robert FPresident and COO | Open-market sale · 10b5-1 plan | SELL | $4,999 52 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 5 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | $419K 51.6K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 5 | Hanna John Walter JRDirector, President and CEO | Option exercise · 10b5-1 plan | M | $5,789 706 sh | Jun 30, 2026 traded Jun 4, 2026 |
| 4 | Hug JoshuaDirector | Open-market sale · 10b5-1 plan | SELL | $386K 16.8K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 4 | Katz ZacharyCLO and Head of Global Affairs | Open-market sale · 10b5-1 plan | SELL | $188K 12.8K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 4 | Hug JoshuaDirector | Open-market sale · 10b5-1 plan | SELL | $379K 16.8K sh | Jun 30, 2026 traded Jun 30, 2026 |
| 4 | Talasaz AmirAliDirector, Co-Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 111.8K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 3 | Silberman Michael WChief Legal Officer | Option exercise · 10b5-1 plan | M | — 30.0K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 3 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | — 24.9K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 3 | Puri SumeetChief Accounting Officer | Option exercise · 10b5-1 plan | M | — 17.6K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 3 | Daunt JohnEVP, Chief Commercial Officer | Option exercise · 10b5-1 plan | M | — 3,287 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 2 | Daunt JohnEVP, Chief Commercial Officer | Option exercise · 10b5-1 plan | M | $71K 3,287 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 2 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | $211K 24.9K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 2 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | $100K 24.9K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 2 | Talasaz AmirAliDirector, Co-Chief Executive Officer | Option exercise · 10b5-1 plan | M | $598K 143.0K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 2 | Talasaz AmirAliDirector, Co-Chief Executive Officer | Option exercise · 10b5-1 plan | M | $467K 111.8K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 1 | Bliss KellyPresident, U.S. Group Health | Open-market sale · 10b5-1 plan | SELL | $21K 2,500 sh | Jun 30, 2026 traded Jun 29, 2026 |
| 1 | Daunt JohnEVP, Chief Commercial Officer | Open-market sale · 10b5-1 plan | SELL | $1,528 39 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Morris Matthew ShawnDirector | Option exercise · 10b5-1 plan | M | — 63.2K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Hanna John Walter JRDirector, President and CEO | Option exercise · 10b5-1 plan | M | — 100 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | $22K 1,837 sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Kroeker NathanCCO and Interim CFO | Option exercise · 10b5-1 plan | M | — 70.6K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | $134K 11.0K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Feider StephenChief Financial Officer | Option exercise · 10b5-1 plan | M | $25K 4,896 sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | — 11.0K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Morris Matthew ShawnDirector | Option exercise · 10b5-1 plan | M | — 88.1K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Mountcastle DavidEVP & Chief Financial Officer | Option exercise · 10b5-1 plan | M | — 1,001 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Mountcastle DavidEVP & Chief Financial Officer | Option exercise · 10b5-1 plan | M | — 1,336 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Mountcastle DavidEVP & Chief Financial Officer | Option exercise · 10b5-1 plan | M | — 8,897 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Hanna John Walter JRDirector, President and CEO | Option exercise · 10b5-1 plan | M | — 39.9K sh | Jun 30, 2026 traded Jun 29, 2026 |